The marine polyarsenical metabolite arsenicin A is the landmark of a series of natural and synthetic molecules characterized by an adamantane-like tetraarsenic cage. Arsenicin A and related polyarsenicals have been evaluated for their antitumor effects in vitro and have been proven more potent than the FDA-approved arsenic trioxide. In this context, we have expanded the chemical space of polyarsenicals related to arsenicin A by synthesizing dialkyl and dimethyl thio-analogs, the latter characterized with the support of simulated NMR spectra. In addition, the new natural arsenicin D, the scarcity of which in the Echinochalina bargibanti extract had previously limited its full structural characterization, has been identified by synthesis. The dialkyl analogs, which present the adamantane-like arsenicin A cage substituted with either two methyl, ethyl, or propyl chains, were efficiently and selectively produced and evaluated for their activity on glioblastoma stem cells (GSCs), a promising therapeutic target in glioblastoma treatment. These compounds inhibited the growth of nine GSC lines more potently than arsenic trioxide, with GI50 values in the submicromolar range, both under normoxic and hypoxic conditions, and presented high selectivity toward non-tumor cell lines. The diethyl and dipropyl analogs, which present favorable physical-chemical and ADME parameters, had the most promising results.

Expanding the Chemical Space of Arsenicin A-C Related Polyarsenicals and Evaluation of Some Analogs as Inhibitors of Glioblastoma Stem Cell Growth / Vigna, Jacopo; Sighel, Denise; Rosatti, Emanuele Filiberto; Defant, Andrea; Pancher, Michael; Sidarovich, Viktoryia; Quattrone, Alessandro; Mancini, Ines. - In: MARINE DRUGS. - ISSN 1660-3397. - 21:3(2023), pp. 18601-18621. [10.3390/md21030186]

Expanding the Chemical Space of Arsenicin A-C Related Polyarsenicals and Evaluation of Some Analogs as Inhibitors of Glioblastoma Stem Cell Growth

Vigna, Jacopo;Sighel, Denise;Rosatti, Emanuele Filiberto;Pancher, Michael;Sidarovich, Viktoryia;Quattrone, Alessandro;Mancini, Ines
2023-01-01

Abstract

The marine polyarsenical metabolite arsenicin A is the landmark of a series of natural and synthetic molecules characterized by an adamantane-like tetraarsenic cage. Arsenicin A and related polyarsenicals have been evaluated for their antitumor effects in vitro and have been proven more potent than the FDA-approved arsenic trioxide. In this context, we have expanded the chemical space of polyarsenicals related to arsenicin A by synthesizing dialkyl and dimethyl thio-analogs, the latter characterized with the support of simulated NMR spectra. In addition, the new natural arsenicin D, the scarcity of which in the Echinochalina bargibanti extract had previously limited its full structural characterization, has been identified by synthesis. The dialkyl analogs, which present the adamantane-like arsenicin A cage substituted with either two methyl, ethyl, or propyl chains, were efficiently and selectively produced and evaluated for their activity on glioblastoma stem cells (GSCs), a promising therapeutic target in glioblastoma treatment. These compounds inhibited the growth of nine GSC lines more potently than arsenic trioxide, with GI50 values in the submicromolar range, both under normoxic and hypoxic conditions, and presented high selectivity toward non-tumor cell lines. The diethyl and dipropyl analogs, which present favorable physical-chemical and ADME parameters, had the most promising results.
2023
3
Vigna, Jacopo; Sighel, Denise; Rosatti, Emanuele Filiberto; Defant, Andrea; Pancher, Michael; Sidarovich, Viktoryia; Quattrone, Alessandro; Mancini, Ines
Expanding the Chemical Space of Arsenicin A-C Related Polyarsenicals and Evaluation of Some Analogs as Inhibitors of Glioblastoma Stem Cell Growth / Vigna, Jacopo; Sighel, Denise; Rosatti, Emanuele Filiberto; Defant, Andrea; Pancher, Michael; Sidarovich, Viktoryia; Quattrone, Alessandro; Mancini, Ines. - In: MARINE DRUGS. - ISSN 1660-3397. - 21:3(2023), pp. 18601-18621. [10.3390/md21030186]
File in questo prodotto:
File Dimensione Formato  
Marine drugs 2023 Supplementary Material .pdf

accesso aperto

Tipologia: Altro materiale allegato (Other attachments)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 1.47 MB
Formato Adobe PDF
1.47 MB Adobe PDF Visualizza/Apri
Marine Drugs_Issue Cover for Volume 21 Issue 3_OK.png

accesso aperto

Descrizione: Cover page of the issue
Tipologia: Altro materiale allegato (Other attachments)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 2.13 MB
Formato image/png
2.13 MB image/png Visualizza/Apri
Marine Drugs2023.pdf

accesso aperto

Descrizione: paper
Tipologia: Versione editoriale (Publisher’s layout)
Licenza: Creative commons
Dimensione 3.7 MB
Formato Adobe PDF
3.7 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11572/374469
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact